AGNG


Aging Population ETF

Fund Summary

The Global X Aging Population ETF (AGNG) seeks to invest in companies positioned to serve the world’s growing senior population through exposure to health care, pharmaceuticals, senior living facilities and other sectors that contribute to increasing lifespans and extending quality of life in advanced age.

Fund Objective

The Global X Aging Population ETF (AGNG) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Aging Population Thematic Index.

Why AGNG?

High Growth Potential

AGNG enables investors to access high growth potential through companies at the leading edge of a long-term, structural demographic trend affecting multiple sectors of the global economy.

Unconstrained Approach

AGNG's composition transcends classic sector, industry, and geographic classifications by tracking an emerging theme.

ETF Efficiency

In a single trade, AGNG delivers access to dozens of companies with high exposure to the Longevity theme.

Fund Details As of 06/16/21

Key Facts

Ticker AGNG
Inception Date 05/09/16
CUSIP 37954Y772
ISIN US37954Y7720
Bloomberg Index Ticker ILNGRNT
Primary Exchange Nasdaq
Number of Holdings 99

Stats & Fees

Net Assets $45,953,014
Net Asset Value (NAV) $30.43
Shares Outstanding 1,510,000
Total Expense Ratio 0.50%

Distributions

30-Day SEC Yield 0.67%
Distribution Frequency Semi-Annually

Fund Prices As of 06/16/21

NAV $30.43 Daily Change -$0.10 -0.34%
Market Price $30.39 Daily Change -$0.21 -0.70%
30-Day Median Bid-Ask Spread 0.27%

Performance History

As of recent
(03/31/21)
As of recent
(03/31/21)
Fund NAV Market Price Index
1 Year 37.23% 37.70% 37.64%
3 Years 12.81% 12.79% 13.07%
Since Inception 13.85% 14.40% 14.16%
1 Year 21.08% 20.93% 21.71%
3 Years 13.66% 13.55% 13.99%
5 Years 14.18% 14.16% 14.55%
Since Inception 14.57% 15.04% 14.94%
Year-to-Date -1.25% -0.61% -1.22%
1 Month -0.36% -0.22% -0.37%
3 Months -1.25% -0.61% -1.22%
Since Inception 88.63% 93.16% 91.25%
Year-to-Date 4.18% 4.55% 4.51%
1 Month 0.76% 0.72% 0.99%
3 Months 5.11% 4.96% 5.40%
Since Inception 98.99% 103.19% 102.34%

Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance of the Fund, when observed, is unusual and investors should not expect such performance to be repeated.

Fund Characteristics As of 06/16/21

Return on Equity 15.10%
Weighted Avg. Market Cap 76,822 M
2020 2021
Price-to-earnings 33.01 27.93
Price-to-book value 4.43 4.02

Source: AltaVista Research, LLC

Fund Risk Stats As of 06/16/21

Versus Beta
S&P 500 0.83
MSCI EAFE 0.79
MSCI Emg. Mkts 0.65
Standard Deviation 18.50%

Source: AltaVista Research, LLC

Sector Breakdown As of 05/31/21

% of Net Assets
Health Care 93.6
Real Estate 5.0
Information Technology 0.7
Communication Services 0.4
Industrials 0.3

Source: AltaVista Research, LLC

Country Breakdown As of 05/31/21

% of Net Assets
United States 56.1
Switzerland 7.9
Japan 6.8
Denmark 6.3
Britain 5.9
China 5.9
Ireland 3.3
South Korea 1.9
Germany 1.4
Belgium 1.3
France 0.7
Other/Cash 2.5

Source: AltaVista Research, LLC

Top Holdings As of 06/16/21

Net Assets (%) Ticker Name SEDOL Market Price ($) Shares Held Market Value ($)
3.42 NOVOB DC NOVO NORDISK A/S-B BHC8X90 84.59 18,587 1,572,302.30
3.39 LLY ELI LILLY & CO 2516152 220.76 7,053 1,557,020.28
3.33 EW EDWARDS LIFESCIENCES CORP 2567116 100.14 15,296 1,531,741.44
3.32 RO SW ROCHE HOLDING AG-BR 7108918 413.59 3,689 1,525,746.93
3.31 AZN ASTRAZENECA PLC-SPONS ADR 2989044 58.41 26,011 1,519,302.51
3.26 BIIB BIOGEN INC 2455965 391.31 3,832 1,499,499.92
3.10 BSX BOSTON SCIENTIFIC CORP 2113434 42.78 33,244 1,422,178.32
3.08 REGN REGENERON PHARMACEUTICALS 2730190 523.58 2,703 1,415,236.74
3.05 ABBV ABBVIE INC B92SR70 115.53 12,134 1,401,841.02
3.03 BMY BRISTOL-MYERS SQUIBB CO 2126335 66.92 20,792 1,391,400.64
2.90 MDT MEDTRONIC PLC BTN1Y11 125.02 10,668 1,333,713.36
2.88 4519 JP CHUGAI PHARMA CO 6196408 41.07 32,209 1,322,694.39
2.88 SYK STRYKER CORP 2853688 256.40 5,152 1,320,972.80
2.83 JNJ JOHNSON & JOHNSON 2475833 164.43 7,900 1,298,997.00
2.72 AMGN AMGEN INC 2023607 239.58 5,212 1,248,690.96
2.14 DXCM DEXCOM INC B0796X4 403.75 2,434 982,727.50
1.95 ALC SW ALCON INC BJT1GR5 71.37 12,582 898,004.47
1.85 WELL WELLTOWER INC BYVYHH4 80.80 10,517 849,773.60
1.83 068270 KS CELLTRION INC B0C5YV1 243.01 3,467 842,506.60
1.81 4503 JP ASTELLAS PHARMA INC 6985383 17.75 46,954 833,423.36
1.81 ZBH ZIMMER BIOMET HO 2783815 158.03 5,248 829,341.44
1.74 4543 JP TERUMO CORP 6885074 41.70 19,203 800,816.36
1.68 BGNE BEIGENE LTD-ADR BYYWPW6 333.31 2,312 770,612.72
1.57 GMAB DC GENMAB A/S 4595739 442.76 1,627 720,365.51
1.51 SGEN SEAGEN INC BLPK4D2 151.32 4,575 692,289.00
1.37 FME GR FRESENIUS MEDICA 5129074 84.81 7,404 627,924.52
1.35 STMN SW STRAUMANN HOLDING AG-REG 7156832 1,557.37 397 618,276.88
1.31 3692 HK HANSOH PHARMACEU BJYKB72 4.10 147,000 603,215.81
1.26 SOON SW SONOVA HOLDING AG-REG 7156036 361.87 1,604 580,434.06
1.22 NVCR NOVOCURE LTD BYSS4X4 220.60 2,539 560,103.40
1.14 VTR VENTAS INC 2927925 57.77 9,102 525,822.54
1.10 EXAS EXACT SCIENCES CORP 2719951 120.38 4,192 504,632.96
1.08 UCB BB UCB SA 5596991 103.64 4,805 497,998.67
1.03 SN/ LN SMITH & NEPHEW PLC 0922320 21.85 21,715 474,548.58
1.02 TFX TELEFLEX INC 2881407 395.97 1,184 468,828.48
1.00 PODD INSULET CORP B1XGNW4 279.49 1,638 457,804.62
0.98 INCY INCYTE CORP 2471950 83.12 5,430 451,341.60
0.78 853 HK MICROPORT SCIENTIFIC CORP B676TW7 7.96 44,800 356,419.06
0.74 DEMANT DC DEMANT A/S BZ01RF1 57.13 5,961 340,570.29
0.74 ABMD ABIOMED INC 2003698 303.30 1,120 339,696.00
0.73 DVA DAVITA INC 2898087 122.78 2,742 336,662.76
0.67 GN DC GN STORE NORD A/S 4501093 87.08 3,526 307,060.87
0.66 COH AU COCHLEAR LTD 6211798 186.51 1,621 302,334.27
0.60 AMP IM AMPLIFON SPA B14NJ71 48.74 5,607 273,300.05
0.50 NBIX NEUROCRINE BIOSC 2623911 98.59 2,313 228,038.67
0.48 DNLI DENALI THERAPEUTICS INC BD2B4V0 73.61 2,966 218,327.26
0.46 OHI OMEGA HEALTHCARE 2043274 37.24 5,695 212,081.80
0.45 ORP FP ORPEA 7339451 129.86 1,590 206,469.73
0.44 UTHR UNITED THERAPEUTICS CORP 2430412 183.44 1,093 200,499.92
0.43 AMED AMEDISYS INC 2024332 242.57 810 196,481.70
0.37 FGEN FIBROGEN INC BSDRYR8 25.84 6,651 171,861.84
0.37 EXEL EXELIXIS INC 2576941 22.43 7,660 171,813.80
0.36 1858 HK BEIJING CHUNLI-H BVVPXP6 3.29 50,300 165,254.81
0.35 INGN INOGEN INC BJSVLL5 66.61 2,389 159,131.29
0.34 BKD BROOKDALE SR B0PZN33 8.75 17,968 157,220.00
0.34 ACAD ACADIA PHARMACEU 2713317 25.90 6,050 156,695.00
0.34 LHCG LHC GROUP INC B06DT50 197.56 780 154,096.80
0.33 HALO HALOZYME THERAPEUTICS INC 2975098 43.10 3,545 152,789.50
0.33 1302 HK LIFETECH SCIENTIFIC CORP BV9FKS0 0.60 254,200 151,308.55
0.32 2186 HK LUYE PHARMA GROUP LTD BNQ4GF3 0.66 221,547 147,286.02
0.31 AED BB AEDIFICA B1G5XP1 137.19 1,045 143,360.60
0.31 ALEC ALECTOR INC BJ4LDC4 22.43 6,363 142,722.09
0.31 1789 HK AK MEDICAL HOLDINGS LTD BFD6SZ0 1.55 91,600 142,327.47
0.31 8086 JP NIPRO CORP 6641599 12.53 11,346 142,205.54
0.31 BLUE BLUEBIRD BIO INC BBFL7S1 32.78 4,332 142,002.96
0.30 AGIO AGIOS PHARMACEUTICALS INC BCBVTX1 58.78 2,365 139,014.70
0.30 CSH-U CN CHARTWELL RETIRE B8S8C94 10.74 12,785 137,308.32
0.29 EPZM EPIZYME INC B9Z1QZ7 8.83 14,849 131,116.67
0.29 ANGO ANGIODYNAMICS INC B00CR04 25.33 5,174 131,057.42
0.28 ITGR INTEGER HOLDINGS CORP BD06LM7 94.02 1,373 129,089.46
0.28 LIVN LIVANOVA PLC BYMT0J1 82.29 1,567 128,948.43
0.28 MMSI MERIT MEDICAL SYSTEMS INC 2580555 61.70 2,089 128,891.30
0.28 EKTAB SS ELEKTA AB-B SHS B0M42T2 14.10 9,133 128,763.73
0.27 TCMD TACTILE SYSTEMS BZB1XF2 52.21 2,412 125,930.52
0.27 2500 HK VENUS MEDTECH -H BL6V047 8.53 14,700 125,377.98
0.27 MNKD MANNKIND CORP BF081J4 4.33 28,952 125,362.16
0.27 SILK SILK ROAD MEDICAL INC BGHVXJ7 49.33 2,514 124,015.62
0.27 CASH 1.00 123,695 123,703.36
0.27 NUVA NUVASIVE INC B00GJC2 66.61 1,856 123,628.16
0.27 KORI FP KORIAN B1HKRM0 37.16 3,303 122,729.18
0.27 NHC NATIONAL HEALTHCARE CORP 2139731 74.23 1,651 122,553.73
0.27 ARNA ARENA PHARMACEUTICALS INC BF3N4P3 64.64 1,883 121,717.12
0.26 BPMC BLUEPRINT MEDICINES CORP BWY52P3 85.56 1,419 121,409.64
0.26 SBRA SABRA HEALTH CAR B5NLBP6 17.86 6,764 120,805.04
0.26 RDUS RADIUS HEALTH INC BM68KK1 18.91 6,292 118,981.72
0.26 4547 JP KISSEI PHARM CO 6494061 20.18 5,880 118,674.97
0.26 GKOS GLAUKOS CORP BYMWL19 80.11 1,474 118,082.14
0.25 PNTG PENNANT GROUP INC/THE BKTC976 41.00 2,841 116,481.00
0.25 ENSG ENSIGN GROUP INC/THE B1YWPP8 84.93 1,350 114,655.50
0.25 HRTX HERON THERAPEUTICS INC BJ0XLZ3 15.75 7,244 114,093.00
0.25 RYM NZ RYMAN HEALTHCARE LTD 6161525 9.32 12,215 113,807.60
0.24 LTC LTC PROPERTIES INC 2498788 38.99 2,864 111,667.36
0.24 NHI NATL HEALTH INVESTORS INC 2626125 65.76 1,674 110,082.24
0.23 DHC DIVERSIFIED HEAL BKRN595 4.15 25,962 107,742.30
0.23 ATEC ALPHATEC HOLDINGS INC BD60BG7 14.88 7,196 107,076.48
0.23 AERI AERIE PHARMACEUTICALS INC BFRTDG1 16.12 6,588 106,198.56
0.23 OMER OMEROS CORP B4NB858 15.00 7,067 106,005.00
0.23 TBPH THERAVANCE BIOPHARMA INC BMNDK09 18.28 5,744 105,000.32
0.22 AMRN AMARIN CORP PLC -ADR 2301938 4.89 20,779 101,609.31
0.22 PHM SM PHARMA MAR SA BMW2GT8 93.07 1,079 100,426.83
Holdings are subject to change.


Investing involves risk, including the possible loss of principal. The investable universe of companies in which AGNG may invest may be limited. The Fund invests in securities of companies engaged in Healthcare, Pharmaceutical, Biotechnology and Medical Device sectors. These sectors can be affected by government regulations, expiring patents, rapid product obsolescence, and intense industry competition. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations. AGNG is non-diversified.

Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.

Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.

Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Indxx, nor does Indxx make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Indxx.

AGNG traded under the ticker LNGR from inception until April 1, 2021.